Claus Garbe

Professor of Dermatology

Eberhard Karls Universität Tübingen

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Claus Garbe is a Professor of Dermatology at Eberhard Karls Universität Tübingen, Germany. His research focuses on skin cancer, particularly cutaneous squamous cell carcinoma, melanoma, and the complexities of their treatment, as evidenced by his recent publications. He is involved in studies addressing the epidemiology and operational classifications of skin cancers, as well as the evaluation of sentinel lymph node biopsy in melanoma prognosis.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (14)

Dominik T. Schneider

GERMANY

View details

Cord Sunderkötter

Professor and chair

Martin-Luther-Universität Halle-Wittenberg Medizinische Fakultät

GERMANY

View details

Ana Arance

University of Barcelona

SPAIN

View details

Joachim Schuz

Head of Section

FRANCE

View details

Helen Gogas

Head, Professor in Medical Oncology,

National and Kapodistrian University of Athens

GREECE

View details

John Dixon

Adjunct Professor

Swinburne University of Technology

AUSTRALIA

View details

Julia Huynh

Charité - Universitätsmedizin Berlin

GERMANY

View details

Saskia Maria Schnabl

GERMANY

View details

Christopher Zachary

Professor and Chair Emeritus

University of California, Irvine

UNITED STATES

View details

Ann-Sophie Bohne

Universitätsklinikum Schleswig-Holstein Campus Kiel

GERMANY

View details

Dirk Schadendorf

University Hospital Essen

GERMANY

View details

Maria Concetta Fargnoli

ITALY

View details

Paul Lorigan

The University of Manchester

UNITED KINGDOM

View details

Thomas Meyer

Head of Research

university hospital of the ruhr university bochum

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Claus Garbe

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Skin cancer in Europe today and challenges for tomorrow

Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts

Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma

Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients

Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer.

Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023

Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesia

Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma

COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600–Mutant Melanoma

Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment

Development of an Image Analysis-Based Prognosis Score Using Google’s Teachable Machine in Melanoma

Diagnostic and prognostic classification of atypical spitzoid tumours based on histology and genomic aberrations: A prospective cohort study with long-term follow-up

Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry

Collaborators (14)

Dominik T. Schneider

Cord Sunderkötter

Ana Arance

Joachim Schuz

Helen Gogas

John Dixon

Julia Huynh

Saskia Maria Schnabl

Christopher Zachary

Ann-Sophie Bohne

Dirk Schadendorf

Maria Concetta Fargnoli

Paul Lorigan

Thomas Meyer

Make your next move.